| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.522 | 0.02 | 0.588 | Calcium channel L-type activator | 0.588 0.007 DBMET00438 | DBMET00438 | |
| 0.438 | 0.023 | 0.438 | Cardiotonic | 0.331 0.045 DBMET00438 | ||
| 0.411 | 0.056 | 0.581 | Toll-Like receptor agonist | 0.581 0.019 DBMET00438 | DBMET00438 | |
| 0.355 | 0.007 | 0.589 | Bronchodilator | 0.589 0.004 DBMET00438 | DBMET00438 | |
| 0.388 | 0.042 | 0.388 | Spasmolytic | 0.31 0.066 DBMET00438 | ||
| 0.401 | 0.06 | 0.574 | Toll-Like receptor 7 agonist | 0.574 0.02 DBMET00438 | DBMET00438 | |
| 0.37 | 0.109 | 0.49 | Cyclophilin D inhibitor | 0.49 0.053 DBMET00438 | DBMET00438 | |
| 0.342 | 0.091 | 0.54 | Antiobesity | 0.54 0.029 DBMET00438 | DBMET00438 | |
| 0.356 | 0.11 | 0.356 | 5 Hydroxytryptamine release inhibitor | 0.31 0.154 DBMET00438 | ||
| 0.234 | 0.004 | 0.234 | Lanosterol 14 alpha demethylase inhibitor | 0.137 0.017 DBMET00438 | ||
| 0.246 | 0.018 | 0.246 | Cholesterol synthesis inhibitor | 0.11 0.075 DBMET00438 | ||
| 0.257 | 0.046 | 0.301 | Peptidyltransferase inhibitor | 0.301 0.024 DBMET00438 | DBMET00438 | |
| 0.231 | 0.024 | 0.231 | Anesthetic local | 0.188 0.035 DBMET00438 | ||
| 0.244 | 0.07 | 0.244 | Hypolipemic | 0.22 0.082 DBMET00438 | ||
| 0.242 | 0.089 | 0.246 | 5 Hydroxytryptamine uptake stimulant | 0.246 0.085 DBMET00438 | DBMET00438 | |
| 0.163 | 0.011 | 0.163 | Beta tubulin antagonist | 0.158 0.011 DBMET00438 | ||
| 0.15 | 0.009 | 0.15 | Alpha tubulin antagonist | 0.142 0.01 DBMET00438 | ||
| 0.2 | 0.071 | 0.2 | Non-steroidal antiinflammatory agent | 0.138 0.134 DBMET00438 | ||
| 0.253 | 0.124 | 0.253 | Antithrombotic | 0.229 0.145 DBMET00438 | ||
| 0.177 | 0.054 | 0.218 | Acetylcholine M1 receptor antagonist | 0.218 0.035 DBMET00438 | DBMET00438 | |
| 0.275 | 0.155 | 0.275 | Antibacterial | 0.246 0.18 DBMET00438 | ||
| 0.133 | 0.02 | 0.218 | Adrenaline agonist | 0.218 0.005 DBMET00438 | DBMET00438 | |
| 0.172 | 0.058 | 0.172 | Phospholipase A2 inhibitor | 0.169 0.06 DBMET00438 | ||
| 0.16 | 0.047 | 0.188 | Adenylate cyclase stimulant | 0.188 0.02 DBMET00438 | DBMET00438 | |
| 0.126 | 0.015 | 0.126 | Glycine receptor antagonist | 0.093 0.039 DBMET00438 | ||
| 0.194 | 0.083 | 0.273 | Psychostimulant | 0.273 0.051 DBMET00438 | DBMET00438 | |
| 0.253 | 0.144 | 0.312 | Calcium channel activator | 0.312 0.08 DBMET00438 | DBMET00438 | |
| 0.153 | 0.048 | 0.153 | Pregnane X receptor agonist | |||
| 0.135 | 0.031 | 0.135 | Sphingomyelinase inhibitor | 0.102 0.058 DBMET00438 | ||
| 0.113 | 0.011 | 0.164 | Beta 3 adrenoreceptor antagonist | 0.164 0.005 DBMET00438 | DBMET00438 | |
| 0.137 | 0.039 | 0.137 | Butyrylcholinesterase inhibitor | 0.134 0.04 DBMET00438 | ||
| 0.115 | 0.019 | 0.115 | Leukotriene synthesis inhibitor | 0.106 0.023 DBMET00438 | ||
| 0.169 | 0.074 | 0.169 | Sigma receptor agonist | |||
| 0.121 | 0.03 | 0.121 | ABCA1 expression enhancer | |||
| 0.231 | 0.141 | 0.268 | Interleukin 2 agonist | 0.268 0.1 DBMET00438 | DBMET00438 | |
| 0.166 | 0.076 | 0.166 | ATPase inhibitor | |||
| 0.194 | 0.108 | 0.194 | Aldehyde oxidase inhibitor | |||
| 0.245 | 0.159 | 0.245 | Histamine release inhibitor | |||
| 0.142 | 0.06 | 0.142 | Acetylcholinesterase inhibitor | 0.114 0.084 DBMET00438 | ||
| 0.139 | 0.059 | 0.153 | Cholinergic antagonist | 0.153 0.051 DBMET00438 | DBMET00438 | |
| 0.13 | 0.052 | 0.13 | DNA intercalator | 0.108 0.066 DBMET00438 | ||
| 0.233 | 0.171 | 0.248 | GABA C receptor rho-3 antagonist | 0.248 0.156 DBMET00438 | DBMET00438 | |
| 0.169 | 0.108 | 0.235 | Insulin sensitizer | 0.235 0.043 DBMET00438 | DBMET00438 | |
| 0.123 | 0.063 | 0.151 | Acetylcholine muscarinic antagonist | 0.151 0.043 DBMET00438 | DBMET00438 | |
| 0.216 | 0.158 | 0.276 | Vasodilator, peripheral | 0.276 0.11 DBMET00438 | DBMET00438 | |
| 0.079 | 0.026 | 0.079 | Dopamine uptake inhibitor | 0.069 0.031 DBMET00438 | ||
| 0.103 | 0.052 | 0.103 | HIV-1 integrase (Overall Integration) inhibitor | 0.091 0.063 DBMET00438 | ||
| 0.104 | 0.054 | 0.301 | Antiadrenergic | 0.301 0.013 DBMET00438 | DBMET00438 | |
| 0.077 | 0.029 | 0.083 | Adrenaline uptake inhibitor | 0.083 0.025 DBMET00438 | DBMET00438 | |
| 0.068 | 0.023 | 0.085 | Beta 2 adrenoreceptor agonist | 0.085 0.007 DBMET00438 | DBMET00438 | |
| 0.099 | 0.054 | 0.299 | Adrenaline antagonist | 0.299 0.013 DBMET00438 | DBMET00438 | |
| 0.063 | 0.018 | 0.063 | Mineralocorticoid receptor antagonist | 0.061 0.019 DBMET00438 | ||
| 0.213 | 0.17 | 0.213 | Vasodilator, coronary | |||
| 0.135 | 0.092 | 0.135 | Ca2+-transporting ATPase inhibitor | |||
| 0.066 | 0.025 | 0.066 | Bcl-xL inhibitor | |||
| 0.204 | 0.165 | 0.258 | Transcription factor NF kappa B inhibitor | 0.258 0.122 DBMET00438 | DBMET00438 | |
| 0.069 | 0.031 | 0.107 | Acetylcholine M5 receptor antagonist | 0.107 0.016 DBMET00438 | DBMET00438 | |
| 0.052 | 0.015 | 0.073 | Beta adrenoreceptor agonist | 0.073 0.005 DBMET00438 | DBMET00438 | |
| 0.131 | 0.094 | 0.131 | Cholinergic | |||
| 0.119 | 0.084 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | 0.126 0.068 DBMET00438 | DBMET00438 | |
| 0.112 | 0.078 | 0.147 | Acetylcholine antagonist | 0.147 0.052 DBMET00438 | DBMET00438 | |
| 0.074 | 0.041 | 0.096 | Sphingosine 1-phosphate receptor 4 agonist | 0.096 0.027 DBMET00438 | DBMET00438 | |
| 0.086 | 0.055 | 0.086 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.081 0.062 DBMET00438 | ||
| 0.042 | 0.012 | 0.042 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.069 | 0.04 | 0.12 | Beta adrenoreceptor antagonist | 0.12 0.01 DBMET00438 | DBMET00438 | |
| 0.096 | 0.067 | 0.096 | 5-Lipoxygenase inhibitor | |||
| 0.06 | 0.036 | 0.109 | Beta 1 adrenoreceptor antagonist | 0.109 0.008 DBMET00438 | DBMET00438 | |
| 0.16 | 0.136 | 0.16 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.065 | 0.041 | 0.089 | NMDA receptor agonist | 0.089 0.024 DBMET00438 | DBMET00438 | |
| 0.144 | 0.122 | 0.144 | Death-associated protein kinase 2 inhibitor | |||
| 0.145 | 0.123 | 0.15 | Succinate dehydrogenase inhibitor | 0.15 0.113 DBMET00438 | DBMET00438 | |
| 0.035 | 0.013 | 0.035 | Liver X receptor alpha antagonist | 0.031 0.018 DBMET00438 | ||
| 0.131 | 0.112 | 0.137 | Melanin inhibitor | 0.137 0.102 DBMET00438 | DBMET00438 | |
| 0.131 | 0.112 | 0.131 | Arachidonic acid antagonist | |||
| 0.11 | 0.091 | 0.11 | Tubulin antagonist | 0.109 0.092 DBMET00438 | ||
| 0.045 | 0.027 | 0.045 | Liver X receptor agonist | |||
| 0.19 | 0.174 | 0.19 | Cholesterol antagonist | |||
| 0.241 | 0.225 | 0.241 | Apoptosis agonist | 0.241 0.224 DBMET00438 | ||
| 0.098 | 0.083 | 0.098 | CDC-like kinase 3 inhibitor | 0.098 0.084 DBMET00438 | ||
| 0.08 | 0.066 | 0.082 | T cell inhibitor | 0.082 0.059 DBMET00438 | DBMET00438 | |
| 0.07 | 0.057 | 0.07 | CDC25A inhibitor | 0.067 0.062 DBMET00438 | ||
| 0.06 | 0.047 | 0.06 | Prostaglandin F2 alpha antagonist | |||
| 0.032 | 0.02 | 0.032 | Liver X receptor antagonist | |||
| 0.066 | 0.055 | 0.067 | Amidase inhibitor | 0.067 0.053 DBMET00438 | DBMET00438 | |
| 0.036 | 0.024 | 0.036 | Ceramide glucosyltransferase inhibitor | |||
| 0.049 | 0.038 | 0.092 | Beta 2 adrenoreceptor antagonist | 0.092 0.009 DBMET00438 | DBMET00438 | |
| 0.029 | 0.02 | 0.029 | Liver X receptor beta antagonist | |||
| 0.04 | 0.031 | 0.04 | Plasmepsin II inhibitor | |||
| 0.023 | 0.016 | 0.04 | Beta 1 adrenoreceptor agonist | 0.04 0.005 DBMET00438 | DBMET00438 | |
| 0.045 | 0.039 | 0.045 | Benzodiazepine antagonist | |||
| 0.055 | 0.049 | 0.074 | Acetylcholine M2 receptor antagonist | 0.074 0.034 DBMET00438 | DBMET00438 | |
| 0.175 | 0.17 | 0.175 | Neuropeptide Y2 antagonist | |||
| 0.051 | 0.05 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.023 DBMET00438 | DBMET00438 | |
| 0.042 | 0.041 | 0.046 | Dopamine transporter inhibitor | 0.046 0.036 DBMET00438 | DBMET00438 | |
| 0.063 | 0.062 | 0.063 | MDM2 inhibitor | |||
| 0.085 | 0.084 | 0.085 | Electrolyte absorption antagonist | |||
| 0.04 | 0.039 | 0.041 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 DBMET00438 | DBMET00438 | |
| 0.013 | 0.013 | 0.033 | Calcium-sensing receptor antagonist | 0.033 0.006 DBMET00438 | DBMET00438 | |
| 0.089 | 0.094 | 0.094 | Nav1.4 sodium channel blocker | 0.094 0.086 DBMET00438 | DBMET00438 | |
| 0.075 | 0.08 | 0.077 | Thioredoxin reductase inhibitor | 0.077 0.072 DBMET00438 | DBMET00438 | |
| 0.007 | 0.016 | 0.022 | Beta 3 adrenoreceptor agonist | 0.022 0.005 DBMET00438 | DBMET00438 | |
| 0.048 | 0.058 | 0.071 | Acetylcholine M3 receptor antagonist | 0.071 0.031 DBMET00438 | DBMET00438 | |
| 0.056 | 0.068 | 0.072 | Sirtuin 1 inhibitor | 0.072 0.042 DBMET00438 | DBMET00438 | |
| 0.023 | 0.037 | 0.034 | Sirtuin 2 inhibitor | 0.034 0.022 DBMET00438 | DBMET00438 | |
| 0.022 | 0.041 | 0.027 | Lysophosphatidic acid 2 receptor antagonist | 0.027 0.026 DBMET00438 | DBMET00438 | |
| 0.091 | 0.11 | 0.115 | Nav1.3 sodium channel blocker | 0.115 0.079 DBMET00438 | DBMET00438 | |
| 0.078 | 0.102 | 0.09 | Anabolic | 0.09 0.078 DBMET00438 | DBMET00438 | |
| 0.131 | 0.155 | 0.164 | Neurotensin receptor agonist | 0.164 0.073 DBMET00438 | DBMET00438 | |
| 0.086 | 0.113 | 0.102 | Factor V inhibitor | 0.102 0.064 DBMET00438 | DBMET00438 | |
| 0.097 | 0.125 | 0.147 | Histone deacetylase SIRT1 inhibitor | 0.147 0.064 DBMET00438 | DBMET00438 | |
| 0.016 | 0.044 | 0.031 | Glucagon receptor antagonist | 0.031 0.019 DBMET00438 | DBMET00438 | |
| 0.182 | 0.214 | 0.206 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 DBMET00438 | DBMET00438 | |
| 0.097 | 0.132 | 0.125 | Sphingosine 1-phosphate receptor 4 antagonist | 0.125 0.064 DBMET00438 | DBMET00438 | |
| 0.068 | 0.106 | 0.129 | Aminoacyl-tRNA synthetase inhibitor | 0.129 0.026 DBMET00438 | DBMET00438 | |
| 0.145 | 0.192 | 0.278 | 5 Hydroxytryptamine release stimulant | 0.278 0.077 DBMET00438 | DBMET00438 | |
| 0.058 | 0.106 | 0.077 | NMDA receptor antagonist | 0.077 0.069 DBMET00438 | DBMET00438 | |
| 0.06 | 0.117 | 0.074 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.059 DBMET00438 | DBMET00438 | |
| 0.101 | 0.165 | 0.127 | Hemostatic | 0.127 0.101 DBMET00438 | DBMET00438 | |
| 0.011 | 0.075 | 0.022 | Alpha 1a adrenoreceptor agonist | 0.022 0.016 DBMET00438 | DBMET00438 | |
| 0.057 | 0.12 | 0.07 | Vanilloid 4 agonist | 0.07 0.066 DBMET00438 | DBMET00438 | |
| 0.135 | 0.208 | 0.175 | Hypoglycemic | 0.175 0.14 DBMET00438 | DBMET00438 | |
| 0.029 | 0.106 | 0.057 | NMDA receptor glycine site agonist | 0.057 0.049 DBMET00438 | DBMET00438 | |
| 0.159 | 0.243 | 0.217 | Immunosuppressant | 0.217 0.179 DBMET00438 | DBMET00438 | |
| 0.063 | 0.16 | 0.096 | Histone deacetylase class III inhibitor | 0.096 0.094 DBMET00438 | DBMET00438 | |
| 0.087 | 0.208 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.085 DBMET00438 | DBMET00438 | |
| 0.094 | 0.223 | 0.219 | Interleukin agonist | 0.219 0.103 DBMET00438 | DBMET00438 | |
| 0.13 | 0.264 | 0.254 | Calpain 2 inhibitor | 0.254 0.147 DBMET00438 | DBMET00438 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |